chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 37.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Blood glucose increased, Condition aggravated, Ejection fraction decreased, Electrocardiogram ST segment elevation, Hyperlipidaemia
Clinical narrative: This study case was received from the investigator (MILVAX) in a trial on 02 March 2011. A 37-year-old male subject was found to have on 09 July 2010 acute pericarditis (17 days after vaccine) and was found to have on 16 July 2010 other and unspecified acute myocarditis 24 days after receiving an injection (route and site not reported) of ACAM2000, lot number not reported, on 22 June 2010. The subject received an injection (route and site not reported) of Anthrax, lot number not reported, on 01 June 2010. The subject had a history of elevated cholesterol and dizziness and fainting spells. On 05 July 2010 the subject had an electrocardiogram performed which was reported as abnormal. On 09 July 2010, the subject was diagnosed with acute pericarditis and on 16 July 2010 he was diagnosed with other and unspecified acute myocarditis. The subject's troponin I of 00.12 from the 22 July 2010 was reported as abnormal. On 22 July 2010, the subject had an echocardiogram performed which was normal. The outcome was not reported. Additional information will be requested from the investigator. Follow-up information was received on 24 May 2011 via a third party query tool search on the VAERS database which contained VAERS ID number 418269. No additional information was received. Documents held by sender: None.
Age: 37.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Left ventricular dysfunction, Loss of consciousness, Myopericarditis, Pericarditis, Syncope
Clinical narrative: This study case was received from the investigator (MILVAX) in a trial on 02 March 2011. A 37-year-old male subject was found to have on 09 July 2010 acute pericarditis (17 days after vaccine) and was found to have on 16 July 2010 other and unspecified acute myocarditis 24 days after receiving an injection (route and site not reported) of ACAM2000, lot number not reported, on 22 June 2010. The subject received an injection (route and site not reported) of Anthrax, lot number not reported, on 01 June 2010. The subject had a history of elevated cholesterol and dizziness and fainting spells. On 05 July 2010 the subject had an electrocardiogram performed which was reported as abnormal. On 09 July 2010, the subject was diagnosed with acute pericarditis and on 16 July 2010 he was diagnosed with other and unspecified acute myocarditis. The subject's troponin I of 00.12 from the 22 July 2010 was reported as abnormal. On 22 July 2010, the subject had an echocardiogram performed which was normal. The outcome was not reported. Additional information will be requested from the investigator. Follow-up information was received on 24 May 2011 via a third party query tool search on the VAERS database which contained VAERS ID number 418269. No additional information was received. Documents held by sender: None.
Age: 37.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Echocardiogram normal, Electrocardiogram abnormal, Myocarditis, Pericarditis, Troponin I increased
Clinical narrative: This study case was received from the investigator (MILVAX) in a trial on 02 March 2011. A 37-year-old male subject was found to have on 09 July 2010 acute pericarditis (17 days after vaccine) and was found to have on 16 July 2010 other and unspecified acute myocarditis 24 days after receiving an injection (route and site not reported) of ACAM2000, lot number not reported, on 22 June 2010. The subject received an injection (route and site not reported) of Anthrax, lot number not reported, on 01 June 2010. The subject had a history of elevated cholesterol and dizziness and fainting spells. On 05 July 2010 the subject had an electrocardiogram performed which was reported as abnormal. On 09 July 2010, the subject was diagnosed with acute pericarditis and on 16 July 2010 he was diagnosed with other and unspecified acute myocarditis. The subject's troponin I of 00.12 from the 22 July 2010 was reported as abnormal. On 22 July 2010, the subject had an echocardiogram performed which was normal. The outcome was not reported. Additional information will be requested from the investigator. Follow-up information was received on 24 May 2011 via a third party query tool search on the VAERS database which contained VAERS ID number 418269. No additional information was received. Documents held by sender: None.
Age: 49.0
Sex: M
Vaccine: SMALL
Symptoms: Generalised vaccinia
Clinical narrative: This case was received on 30 September 2010 via a QScan search on the VAERS database, under reference number 392878. A 49-year-old male patient received the following vaccination on 01 June 2010: a percutaneous right arm ACAM2000 (lot number not reported). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. The patient had no medical history and no illness at the time of vaccination. On 01 July 2010, the patient developed generalized vaccinia. He required an Emergency visit. The outcome was reported as recovered. Documents held by sender: None.
Age: 23.0
Sex: M
Vaccine: SMALL
Symptoms: Injection site reaction, Lethargy, Pallor, Rash maculo-papular, Skin lesion
Clinical narrative: This case was received on 30 September 2010 via a QScan search on the VAERS database, under reference number 393001. A 23-year-old male patient received the following vaccination on 07 July 2010: a percutaneous right arm ACAM2000 (lot number VV04003A). The patient had no medical history and no illness at the time of vaccination. It was unknown if the patient was taking other medications. On 15 July 2010, the patient developed numerous satellite lesions to right deltoid region and right shoulder. There were numerous lesions on back, scattered lesions on chest, and behind left ear. The patient developed macular papular rash on chest and back. He was pale and lethargic. The patient was sent to the Emergency Department (ED) for evaluation. The outcome was reported as unknown. Documents held by sender: None.
Age: 23.0
Sex: M
Vaccine: SMALL
Symptoms: Vaccination complication
Clinical narrative: This case was received on 30 September 2010 via a QScan search on the VAERS database, under reference number 393001. A 23-year-old male patient received the following vaccination on 07 July 2010: a percutaneous right arm ACAM2000 (lot number VV04003A). The patient had no medical history and no illness at the time of vaccination. It was unknown if the patient was taking other medications. On 15 July 2010, the patient developed numerous satellite lesions to right deltoid region and right shoulder. There were numerous lesions on back, scattered lesions on chest, and behind left ear. The patient developed macular papular rash on chest and back. He was pale and lethargic. The patient was sent to the Emergency Department (ED) for evaluation. The outcome was reported as unknown. Documents held by sender: None.
Age: 23.0
Sex: M
Vaccine: ANTH, HEP, HEPA, SMALL
Symptoms: Blood creatine phosphokinase normal, Chest X-ray normal, Chest discomfort, Dyspnoea, Full blood count normal
Clinical narrative: Initial report received via Q-Scan search of the VAERS database on 30 September 2010. VAERS identification number 393130. A 23-year-old male patient had received a percutaneous dose of ACAM2000 (lot number VV04003A, site unknown); a dose of BIOTHRAX (manufacturer Emergent, lot number FAV231, route and site unknown); an intramuscular dose of ENGERIX-B (manufacturer GlaxoSmithKline, lot number AHAVB765AA); and an intramuscular dose of HAVRIX (manufacturer GlaxoSmithKline, lot number AHBVB302AA) on 18 May 2010. Fifteen days (on 02 June 2010); also reported as approximately 2 weeks post-vaccinations, the patient required emergency visit for pressure in the center of his chest (rated 5 on a scale of 1-10) associated with shortness of breath and diaphoresis (hyperhydrosis). The patient denied nausea. On 18 June 2010 CK (blood creatine phosphokinase), Chem 7, CBC, and chest x-ray were all normal. Medical history for patient was not reported. At the time of this report, recovery status was unknown. Documents  held by sender: None.
Age: 23.0
Sex: M
Vaccine: ANTH, HEP, HEPA, SMALL
Symptoms: Hyperhidrosis, Laboratory test normal
Clinical narrative: Initial report received via Q-Scan search of the VAERS database on 30 September 2010. VAERS identification number 393130. A 23-year-old male patient had received a percutaneous dose of ACAM2000 (lot number VV04003A, site unknown); a dose of BIOTHRAX (manufacturer Emergent, lot number FAV231, route and site unknown); an intramuscular dose of ENGERIX-B (manufacturer GlaxoSmithKline, lot number AHAVB765AA); and an intramuscular dose of HAVRIX (manufacturer GlaxoSmithKline, lot number AHBVB302AA) on 18 May 2010. Fifteen days (on 02 June 2010); also reported as approximately 2 weeks post-vaccinations, the patient required emergency visit for pressure in the center of his chest (rated 5 on a scale of 1-10) associated with shortness of breath and diaphoresis (hyperhydrosis). The patient denied nausea. On 18 June 2010 CK (blood creatine phosphokinase), Chem 7, CBC, and chest x-ray were all normal. Medical history for patient was not reported. At the time of this report, recovery status was unknown. Documents  held by sender: None.
Age: 19.0
Sex: M
Vaccine: SMALL
Symptoms: Biopsy site unspecified abnormal, Collagen-vascular disease, Laboratory test normal
Clinical narrative: Initial report received on 30 September 2010 via a QScan search on the VAERS database, under reference number 393313. A 19-year-old male patient received a PPD test (lot number not reported) on 19 June 2010, and 9 days later received a first ACAM2000 (lot number "VV04003A") on 28 June 2010. Twenty-one days post PPD test, and 11 days post-vaccination small pox vaccination, an unevaluable event occurred. Laboratory data included: 4 x 4 x 5mm punch biopsy of right forearm with overall findings that favored evolving collagen-vascular disease over early erythema multiforme, particularly in the context of a subtly smudged basement membrane zone. PAS strain was negative for hyphae. Treatment received were not reported. The patient had no known allergies, and no concurrent illnesses at time of vaccination. The patient recovered. Documents held by sender: None.
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Axillary pain, Erythema, Erythema induratum, Injection site swelling, Lymph node pain
Clinical narrative: This case was received on 30 September 2010 via a QScan search on the VAERS database, under reference number 393490. A male patient (age reported as 0.1) received the following vaccinations on 14 July 2010: a percutaneous left arm ACAM2000 (lot number VV04003A) and a right arm injection of Anthrax (lot number FAV230). The patient had no medical history and no illness at the time of vaccination. Approximately 3 days after vaccination, the patient developed swelling at site, armpit discomfort and erythema. The symptoms and the size increased. There was slight necrosed and ulcerated area approximately 5 days after vaccination. A purple scab was noticed and now the patient has adenopathy with pain. There was a 9 cm red induration, 1 x 1.3 cm lesion with 0.5 cm ulceration. The patient received no treatment at this time. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. Documents held by sender: None.
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Lymphadenopathy, Necrosis, Scab, Skin lesion, Skin ulcer
Clinical narrative: This case was received on 30 September 2010 via a QScan search on the VAERS database, under reference number 393490. A male patient (age reported as 0.1) received the following vaccinations on 14 July 2010: a percutaneous left arm ACAM2000 (lot number VV04003A) and a right arm injection of Anthrax (lot number FAV230). The patient had no medical history and no illness at the time of vaccination. Approximately 3 days after vaccination, the patient developed swelling at site, armpit discomfort and erythema. The symptoms and the size increased. There was slight necrosed and ulcerated area approximately 5 days after vaccination. A purple scab was noticed and now the patient has adenopathy with pain. There was a 9 cm red induration, 1 x 1.3 cm lesion with 0.5 cm ulceration. The patient received no treatment at this time. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. Documents held by sender: None.
Age: 38.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Asthenia, Chest discomfort, Chest pain, Hypotension, Injection site swelling
Clinical narrative: This case was received on 30 September 2010 via a QScan search on the VAERS database, under reference number 393738. A 38-year-old male patient received the following vaccinations on 06 July 2009: a percutaneous left arm ACAM2000 (lot number VV04003A), BIOTHRAX (manufacturer Emergent, lot number FAV206). The patient had no illness at the time of vaccinations. On 14 July 2009, the patient developed swelling at the smallpox site followed by weakness, fever, night sweats and chest discomfort. On 16 July 2009, the patient was found to have an elevated troponin and was hospitalized with life threatening chest pain, hypotension, tachycardia and ischemia. He was diagnosed with myopericarditis and remained hospitalized until 20 July 2009. The outcome was reported as recovered. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. Documents held by sender: None.
Age: 38.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Ischaemia, Myopericarditis, Night sweats, Pyrexia, Tachycardia
Clinical narrative: This case was received on 30 September 2010 via a QScan search on the VAERS database, under reference number 393738. A 38-year-old male patient received the following vaccinations on 06 July 2009: a percutaneous left arm ACAM2000 (lot number VV04003A), BIOTHRAX (manufacturer Emergent, lot number FAV206). The patient had no illness at the time of vaccinations. On 14 July 2009, the patient developed swelling at the smallpox site followed by weakness, fever, night sweats and chest discomfort. On 16 July 2009, the patient was found to have an elevated troponin and was hospitalized with life threatening chest pain, hypotension, tachycardia and ischemia. He was diagnosed with myopericarditis and remained hospitalized until 20 July 2009. The outcome was reported as recovered. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. Documents held by sender: None.
Age: 38.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Troponin increased
Clinical narrative: This case was received on 30 September 2010 via a QScan search on the VAERS database, under reference number 393738. A 38-year-old male patient received the following vaccinations on 06 July 2009: a percutaneous left arm ACAM2000 (lot number VV04003A), BIOTHRAX (manufacturer Emergent, lot number FAV206). The patient had no illness at the time of vaccinations. On 14 July 2009, the patient developed swelling at the smallpox site followed by weakness, fever, night sweats and chest discomfort. On 16 July 2009, the patient was found to have an elevated troponin and was hospitalized with life threatening chest pain, hypotension, tachycardia and ischemia. He was diagnosed with myopericarditis and remained hospitalized until 20 July 2009. The outcome was reported as recovered. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. Documents held by sender: None.
Age: 22.0
Sex: M
Vaccine: SMALL
Symptoms: Erythema of eyelid, Eyelid oedema, Eyelid pain, Eyelids pruritus
Clinical narrative: Initial report was received on 30 September 2010 via a Q-Scan search of the VAERS database, under reference number 393938. A 22-year-old male patient received the following vaccination on 14 July 2010: ACAM2000 (lot number VV04003A). On 24 July 2010, the patient developed itching, redness, pain and swelling of his left lower and upper eyelid. That same day, he went to the emergency room and reported that he thought he may have touched his smallpox site and then rubbed his eye. He was seen by an ophthalmologist and diagnosed with possible ocular vaccinia. He received VIROPTIC, VIGAMOX and erythromycin eye drops as corrective treatment. The patient had not experienced any visual changes or blurring and his vision was 20/20 in both eyes. On 27 July 2010, he followed up with his primary physician and was prescribed oral amoxicillin. On 28 July 2010, he followed-up with the ophthalmologist, and on 29 July 2010, he was again seen by his primary physician. During his 29 July 2010 follow-up visit, his upper eyelid had improved greatly, but his lower eyelid had worsened. He was put on 72 hour quarters and prescribed DARVOCET for pain. The patient had been scheduled to travel to a foreign country on 31 July 2010; however, the ophthalmologist recommended the patient not travel until his symptoms were clear for two weeks. Outcome was reported as not recovered. Documents held by sender: None.
Age: 21.0
Sex: F
Vaccine: SMALL, ANTH, HEPA, SMALL
Symptoms: Chest pain, Echocardiogram, Electrocardiogram, Laboratory test
Clinical narrative: This case was received on 12 October 2010 via a QScan search on the VAERS database, under reference number 394186. A 21-year-old female patient received the following vaccination on 28 July 2010: a percutaneous arm ACAM2000 (lot number not reported). The patient had a medical history of Duane's syndrome and took an over-the -counter product (not specified). She reported no current illnesses. On 31 July 2010, the patient developed chest pain which required an Emergency visit and hospitalization. The patient had an echocardiogram, electrocardiogram and laboratory tests performed (no results provided). The outcome was reported as recovered. Documents held by sender: None.
Age: 21.0
Sex: F
Vaccine: SMALL, ANTH, HEPA, SMALL
Symptoms: Echocardiogram normal, Electrocardiogram abnormal, Myocarditis, Troponin I
Clinical narrative: This case was received on 12 October 2010 via a QScan search on the VAERS database, under reference number 394186. A 21-year-old female patient received the following vaccination on 28 July 2010: a percutaneous arm ACAM2000 (lot number not reported). The patient had a medical history of Duane's syndrome and took an over-the -counter product (not specified). She reported no current illnesses. On 31 July 2010, the patient developed chest pain which required an Emergency visit and hospitalization. The patient had an echocardiogram, electrocardiogram and laboratory tests performed (no results provided). The outcome was reported as recovered. Documents held by sender: None.
Age: 38.0
Sex: M
Vaccine: SMALL
Symptoms: Cardiac enzymes, Chest pain, Dyspnoea, Echocardiogram, Electrocardiogram
Clinical narrative: This case was received on 12 October 2010 via a QScan search on the VAERS database, under reference number 394373. A 38-year-old male patient received the following vaccination on 18 June 2010: a percutaneous left arm ACAM2000 (lot number not reported). The patient had no medical history and no current illnesses. On 30 June 2010, the patient developed chest pain, dyspnoea, fatigue, palpitations and syncope. The patient required an Emergency visit. He had an echocardiogram, electrocardiogram and cardiac enzymes performed (no results provided). The outcome was not reported. Documents held by sender: None.
Age: 38.0
Sex: M
Vaccine: SMALL
Symptoms: Fatigue, Palpitations, Syncope
Clinical narrative: This case was received on 12 October 2010 via a QScan search on the VAERS database, under reference number 394373. A 38-year-old male patient received the following vaccination on 18 June 2010: a percutaneous left arm ACAM2000 (lot number not reported). The patient had no medical history and no current illnesses. On 30 June 2010, the patient developed chest pain, dyspnoea, fatigue, palpitations and syncope. The patient required an Emergency visit. He had an echocardiogram, electrocardiogram and cardiac enzymes performed (no results provided). The outcome was not reported. Documents held by sender: None.
Age: 24.0
Sex: F
Vaccine: SMALL
Symptoms: Acne, Blepharitis, Exposure to vaccinated person, Orthopoxvirus test positive, Polymerase chain reaction
Clinical narrative: This case was received on 12 October 2010 via a QScan search on the VAERS database, under reference number 394391. A 24-year-old female patient who had no concurrent illness, no past medical history, and no history of smallpox vaccination, had developed a vaccinia virus infection from secondary transmission following exposure to the vaccine by touching her boyfriend while sleeping. Her boyfriend had been immunized on his arm with ACAM2000 (lot number unknown). The reported date of vaccination was 21 July 2010. On the evening of Sunday 01 August 2010, the patient noticed a small pimple like sore and she popped the pimple. On the morning of 02 August 2010, the lesion continued to get larger and by that evening, it began to look like the smallpox vaccination site on her boyfriend's arm. On the morning of 03 August 2010, she reported to sick call. The patient had a primary lesion described as an umbilicated pustule above her right eye (on the inferior aspect of the eyebrow on the orbital rim). She had two ocular satellite lesions, one on the inferior orbital rim and another one on the superior aspect to the right of the main lesion. She also had another umbilicated pustule on the right lower extremity. There was no evidence of ocular involvement (e.g., conjunctivitis, keratitis, or frank blepharitis), although there was secondary blepharitis from the periorbital lesions. The patient did not wear contacts. The patient received VIROPTIC (2 gtt OU five times daily) to reduce the possibility of frank ocular involvement. Initial PCR confirmation of vaccinia was received from the laboratory, pending CDC confirmation. During a personal interview, the patient was counseled against getting pregnant for the next 30 days. According to the patient, the vaccination site on her boyfriend was covered with a band-aid and a t-shirt, and that he had received the Smallpox Individuals Briefing prior to being vaccinated. At the time of the report, the patient's outcome was unknown. Document's held by sender: None.
Age: 24.0
Sex: F
Vaccine: SMALL
Symptoms: Rash pustular, Secondary transmission, Skin lesion, Smallpox, Vaccinia virus infection
Clinical narrative: This case was received on 12 October 2010 via a QScan search on the VAERS database, under reference number 394391. A 24-year-old female patient who had no concurrent illness, no past medical history, and no history of smallpox vaccination, had developed a vaccinia virus infection from secondary transmission following exposure to the vaccine by touching her boyfriend while sleeping. Her boyfriend had been immunized on his arm with ACAM2000 (lot number unknown). The reported date of vaccination was 21 July 2010. On the evening of Sunday 01 August 2010, the patient noticed a small pimple like sore and she popped the pimple. On the morning of 02 August 2010, the lesion continued to get larger and by that evening, it began to look like the smallpox vaccination site on her boyfriend's arm. On the morning of 03 August 2010, she reported to sick call. The patient had a primary lesion described as an umbilicated pustule above her right eye (on the inferior aspect of the eyebrow on the orbital rim). She had two ocular satellite lesions, one on the inferior orbital rim and another one on the superior aspect to the right of the main lesion. She also had another umbilicated pustule on the right lower extremity. There was no evidence of ocular involvement (e.g., conjunctivitis, keratitis, or frank blepharitis), although there was secondary blepharitis from the periorbital lesions. The patient did not wear contacts. The patient received VIROPTIC (2 gtt OU five times daily) to reduce the possibility of frank ocular involvement. Initial PCR confirmation of vaccinia was received from the laboratory, pending CDC confirmation. During a personal interview, the patient was counseled against getting pregnant for the next 30 days. According to the patient, the vaccination site on her boyfriend was covered with a band-aid and a t-shirt, and that he had received the Smallpox Individuals Briefing prior to being vaccinated. At the time of the report, the patient's outcome was unknown. Document's held by sender: None.
Age: 28.0
Sex: M
Vaccine: SMALL
Symptoms: Pseudofolliculitis barbae, Rash, Vaccinia virus infection
Clinical narrative: This case was received on 12 October 2010 via a QScan search on the VAERS database, under reference number 394962. A 28-year-old male patient received the following vaccination on 26 May 2010: a percutaneous left arm ACAM2000 (lot number VV04003A). The patient had no medical history and no current illnesses. On 07 June 2010, the patient developed pseudofolliculitis barbae, rash and was diagnosed with vaccinia. The patient woke up 12 days after he had the smallpox vaccine with sudden appearance of rash on his upper chest, back and upper arms. He had no fever, no chills and was asymptomatic except for the rash. He required an emergency visit. The patient had shaved his chest, but unsure if that was prior to smallpox or after vaccination. There were visible shaving bumps present on chest. An infectious disease physician advised to keep area covered and place on convalescent medical leave for 7 days. A diagnosis of vaccinia was noted in his medical records. The outcome was reported as recovered. Documents held by sender: None.
Age: 16.0
Sex: M
Vaccine: FLU3, FLU3, SMALL, FLUX, SMALL, FLUX, SMALL
Symptoms: Aspartate aminotransferase increased, Axillary pain, Blood albumin decreased, Blood amylase normal, Blood calcium decreased
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 397847. A 16-year-old male patient who had no current illnesses, had received the following vaccinations on 28 August 2010: a percutaneous left arm injection of ACAM2000 (lot number W04003A), an intramuscular right arm injection of FLUZONE SV 2010-2011, lot number UH180AD and ten days later, experienced pericarditis possible aseptic meningitis. He was evaluated in the emergency room. Treatments were not reported. No further information was available at the time of the report. The patient's outcome was not reported. A corrective version was created on 22 December 2010 to correct the route of administration from intradermal to percutaneous. Documents held by sender: none.
Age: 16.0
Sex: M
Vaccine: FLU3, FLU3, SMALL, FLUX, SMALL, FLUX, SMALL
Symptoms: Blood creatine phosphokinase MB increased, Blood creatine phosphokinase increased, Blood culture negative, Blood lactate dehydrogenase increased, Blood thyroid stimulating hormone normal
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 397847. A 16-year-old male patient who had no current illnesses, had received the following vaccinations on 28 August 2010: a percutaneous left arm injection of ACAM2000 (lot number W04003A), an intramuscular right arm injection of FLUZONE SV 2010-2011, lot number UH180AD and ten days later, experienced pericarditis possible aseptic meningitis. He was evaluated in the emergency room. Treatments were not reported. No further information was available at the time of the report. The patient's outcome was not reported. A corrective version was created on 22 December 2010 to correct the route of administration from intradermal to percutaneous. Documents held by sender: none.
Age: 16.0
Sex: M
Vaccine: FLU3, FLU3, SMALL, FLUX, SMALL, FLUX, SMALL
Symptoms: C-reactive protein increased, CSF culture negative, CSF glucose increased, CSF protein increased, CSF white blood cell count negative
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 397847. A 16-year-old male patient who had no current illnesses, had received the following vaccinations on 28 August 2010: a percutaneous left arm injection of ACAM2000 (lot number W04003A), an intramuscular right arm injection of FLUZONE SV 2010-2011, lot number UH180AD and ten days later, experienced pericarditis possible aseptic meningitis. He was evaluated in the emergency room. Treatments were not reported. No further information was available at the time of the report. The patient's outcome was not reported. A corrective version was created on 22 December 2010 to correct the route of administration from intradermal to percutaneous. Documents held by sender: none.
Age: 16.0
Sex: M
Vaccine: FLU3, FLU3, SMALL, FLUX, SMALL, FLUX, SMALL
Symptoms: Cardiac stress test normal, Chest X-ray normal, Chest pain, Computerised tomogram head, Computerised tomogram normal
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 397847. A 16-year-old male patient who had no current illnesses, had received the following vaccinations on 28 August 2010: a percutaneous left arm injection of ACAM2000 (lot number W04003A), an intramuscular right arm injection of FLUZONE SV 2010-2011, lot number UH180AD and ten days later, experienced pericarditis possible aseptic meningitis. He was evaluated in the emergency room. Treatments were not reported. No further information was available at the time of the report. The patient's outcome was not reported. A corrective version was created on 22 December 2010 to correct the route of administration from intradermal to percutaneous. Documents held by sender: none.
Age: 16.0
Sex: M
Vaccine: FLU3, FLU3, SMALL, FLUX, SMALL, FLUX, SMALL
Symptoms: Culture negative, Echocardiogram abnormal, Echocardiogram normal, Ejection fraction decreased, Electrocardiogram ST segment elevation
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 397847. A 16-year-old male patient who had no current illnesses, had received the following vaccinations on 28 August 2010: a percutaneous left arm injection of ACAM2000 (lot number W04003A), an intramuscular right arm injection of FLUZONE SV 2010-2011, lot number UH180AD and ten days later, experienced pericarditis possible aseptic meningitis. He was evaluated in the emergency room. Treatments were not reported. No further information was available at the time of the report. The patient's outcome was not reported. A corrective version was created on 22 December 2010 to correct the route of administration from intradermal to percutaneous. Documents held by sender: none.
Age: 16.0
Sex: M
Vaccine: FLU3, FLU3, SMALL, FLUX, SMALL, FLUX, SMALL
Symptoms: Electrocardiogram abnormal, Fatigue, Feeling hot, Fibrin D dimer normal, Full blood count abnormal
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 397847. A 16-year-old male patient who had no current illnesses, had received the following vaccinations on 28 August 2010: a percutaneous left arm injection of ACAM2000 (lot number W04003A), an intramuscular right arm injection of FLUZONE SV 2010-2011, lot number UH180AD and ten days later, experienced pericarditis possible aseptic meningitis. He was evaluated in the emergency room. Treatments were not reported. No further information was available at the time of the report. The patient's outcome was not reported. A corrective version was created on 22 December 2010 to correct the route of administration from intradermal to percutaneous. Documents held by sender: none.
Age: 16.0
Sex: M
Vaccine: FLU3, FLU3, SMALL, FLUX, SMALL, FLUX, SMALL
Symptoms: Gram stain, Gram stain negative, Haematocrit decreased, Headache, Injection site erythema
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 397847. A 16-year-old male patient who had no current illnesses, had received the following vaccinations on 28 August 2010: a percutaneous left arm injection of ACAM2000 (lot number W04003A), an intramuscular right arm injection of FLUZONE SV 2010-2011, lot number UH180AD and ten days later, experienced pericarditis possible aseptic meningitis. He was evaluated in the emergency room. Treatments were not reported. No further information was available at the time of the report. The patient's outcome was not reported. A corrective version was created on 22 December 2010 to correct the route of administration from intradermal to percutaneous. Documents held by sender: none.
Age: 16.0
Sex: M
Vaccine: FLU3, FLU3, SMALL, FLUX, SMALL, FLUX, SMALL
Symptoms: Injection site induration, Lipase normal, Lumbar puncture, Lymphadenopathy, Lymphocyte count decreased
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 397847. A 16-year-old male patient who had no current illnesses, had received the following vaccinations on 28 August 2010: a percutaneous left arm injection of ACAM2000 (lot number W04003A), an intramuscular right arm injection of FLUZONE SV 2010-2011, lot number UH180AD and ten days later, experienced pericarditis possible aseptic meningitis. He was evaluated in the emergency room. Treatments were not reported. No further information was available at the time of the report. The patient's outcome was not reported. A corrective version was created on 22 December 2010 to correct the route of administration from intradermal to percutaneous. Documents held by sender: none.
Age: 16.0
Sex: M
Vaccine: FLU3, FLU3, SMALL, FLUX, SMALL, FLUX, SMALL
Symptoms: Mean cell haemoglobin, Mean cell haemoglobin increased, Metabolic function test, Metabolic function test normal, Monocyte count increased
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 397847. A 16-year-old male patient who had no current illnesses, had received the following vaccinations on 28 August 2010: a percutaneous left arm injection of ACAM2000 (lot number W04003A), an intramuscular right arm injection of FLUZONE SV 2010-2011, lot number UH180AD and ten days later, experienced pericarditis possible aseptic meningitis. He was evaluated in the emergency room. Treatments were not reported. No further information was available at the time of the report. The patient's outcome was not reported. A corrective version was created on 22 December 2010 to correct the route of administration from intradermal to percutaneous. Documents held by sender: none.
Age: 16.0
Sex: M
Vaccine: FLU3, FLU3, SMALL, FLUX, SMALL, FLUX, SMALL
Symptoms: Neutrophil count increased, Nuclear magnetic resonance imaging abnormal, Nuclear magnetic resonance imaging thoracic abnormal, Painful respiration, Prothrombin time normal
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 397847. A 16-year-old male patient who had no current illnesses, had received the following vaccinations on 28 August 2010: a percutaneous left arm injection of ACAM2000 (lot number W04003A), an intramuscular right arm injection of FLUZONE SV 2010-2011, lot number UH180AD and ten days later, experienced pericarditis possible aseptic meningitis. He was evaluated in the emergency room. Treatments were not reported. No further information was available at the time of the report. The patient's outcome was not reported. A corrective version was created on 22 December 2010 to correct the route of administration from intradermal to percutaneous. Documents held by sender: none.
Age: 16.0
Sex: M
Vaccine: FLU3, FLU3, SMALL, FLUX, SMALL, FLUX, SMALL
Symptoms: Pyrexia, Red blood cell count decreased, Red blood cell sedimentation rate increased, Red blood cells CSF positive, Sinus rhythm
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 397847. A 16-year-old male patient who had no current illnesses, had received the following vaccinations on 28 August 2010: a percutaneous left arm injection of ACAM2000 (lot number W04003A), an intramuscular right arm injection of FLUZONE SV 2010-2011, lot number UH180AD and ten days later, experienced pericarditis possible aseptic meningitis. He was evaluated in the emergency room. Treatments were not reported. No further information was available at the time of the report. The patient's outcome was not reported. A corrective version was created on 22 December 2010 to correct the route of administration from intradermal to percutaneous. Documents held by sender: none.
Age: 16.0
Sex: M
Vaccine: FLU3, FLU3, SMALL, FLUX, SMALL, FLUX, SMALL
Symptoms: Troponin I increased, Urine analysis normal, Ventricular hypokinesia
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 397847. A 16-year-old male patient who had no current illnesses, had received the following vaccinations on 28 August 2010: a percutaneous left arm injection of ACAM2000 (lot number W04003A), an intramuscular right arm injection of FLUZONE SV 2010-2011, lot number UH180AD and ten days later, experienced pericarditis possible aseptic meningitis. He was evaluated in the emergency room. Treatments were not reported. No further information was available at the time of the report. The patient's outcome was not reported. A corrective version was created on 22 December 2010 to correct the route of administration from intradermal to percutaneous. Documents held by sender: none.
Age: 16.0
Sex: M
Vaccine: FLU3, FLU3, SMALL, FLUX, SMALL, FLUX, SMALL
Symptoms: Pericarditis
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 397847. A 16-year-old male patient who had no current illnesses, had received the following vaccinations on 28 August 2010: a percutaneous left arm injection of ACAM2000 (lot number W04003A), an intramuscular right arm injection of FLUZONE SV 2010-2011, lot number UH180AD and ten days later, experienced pericarditis possible aseptic meningitis. He was evaluated in the emergency room. Treatments were not reported. No further information was available at the time of the report. The patient's outcome was not reported. A corrective version was created on 22 December 2010 to correct the route of administration from intradermal to percutaneous. Documents held by sender: none.
Age: 16.0
Sex: M
Vaccine: FLU3, FLU3, SMALL, FLUX, SMALL, FLUX, SMALL
Symptoms: Echocardiogram normal, Electrocardiogram abnormal, Pericarditis, Troponin I increased
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 397847. A 16-year-old male patient who had no current illnesses, had received the following vaccinations on 28 August 2010: a percutaneous left arm injection of ACAM2000 (lot number W04003A), an intramuscular right arm injection of FLUZONE SV 2010-2011, lot number UH180AD and ten days later, experienced pericarditis possible aseptic meningitis. He was evaluated in the emergency room. Treatments were not reported. No further information was available at the time of the report. The patient's outcome was not reported. A corrective version was created on 22 December 2010 to correct the route of administration from intradermal to percutaneous. Documents held by sender: none.
Age: 26.0
Sex: M
Vaccine: FLU3, FLU3, SMALL, FLUX, SMALL, FLUX, SMALL
Symptoms: Aspartate aminotransferase increased, Axillary pain, Blood albumin decreased, Blood amylase normal, Blood calcium decreased
Clinical narrative: This study case was received from the investigator on 10 March 2011. A 26 year-old male subject with no significant medical history was found to have other and unspecified acute pericarditis 12 days after he had received an injection of ACAM2000 (lot number, route and site of administration not reported) on 28 August 2010. Relevant laboratory data included: an abnormal Troponin I with the highest recorded value of 02.05, an abnormal ECG and a normal Echocardiogram. Treatments were not reported. Additional information will be requested from the investigator. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Follow-up information was received on 24 May 2011 via a third party query tool search on the VAERS database, and provided VAERS reference number 418965. Documents held by sender: none.
Age: 26.0
Sex: M
Vaccine: FLU3, FLU3, SMALL, FLUX, SMALL, FLUX, SMALL
Symptoms: Blood creatine phosphokinase MB increased, Blood creatine phosphokinase increased, Blood culture negative, Blood lactate dehydrogenase increased, Blood thyroid stimulating hormone normal
Clinical narrative: This study case was received from the investigator on 10 March 2011. A 26 year-old male subject with no significant medical history was found to have other and unspecified acute pericarditis 12 days after he had received an injection of ACAM2000 (lot number, route and site of administration not reported) on 28 August 2010. Relevant laboratory data included: an abnormal Troponin I with the highest recorded value of 02.05, an abnormal ECG and a normal Echocardiogram. Treatments were not reported. Additional information will be requested from the investigator. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Follow-up information was received on 24 May 2011 via a third party query tool search on the VAERS database, and provided VAERS reference number 418965. Documents held by sender: none.
Age: 26.0
Sex: M
Vaccine: FLU3, FLU3, SMALL, FLUX, SMALL, FLUX, SMALL
Symptoms: C-reactive protein increased, CSF culture negative, CSF glucose increased, CSF protein increased, CSF white blood cell count negative
Clinical narrative: This study case was received from the investigator on 10 March 2011. A 26 year-old male subject with no significant medical history was found to have other and unspecified acute pericarditis 12 days after he had received an injection of ACAM2000 (lot number, route and site of administration not reported) on 28 August 2010. Relevant laboratory data included: an abnormal Troponin I with the highest recorded value of 02.05, an abnormal ECG and a normal Echocardiogram. Treatments were not reported. Additional information will be requested from the investigator. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Follow-up information was received on 24 May 2011 via a third party query tool search on the VAERS database, and provided VAERS reference number 418965. Documents held by sender: none.
Age: 26.0
Sex: M
Vaccine: FLU3, FLU3, SMALL, FLUX, SMALL, FLUX, SMALL
Symptoms: Cardiac stress test normal, Chest X-ray normal, Chest pain, Computerised tomogram head, Computerised tomogram normal
Clinical narrative: This study case was received from the investigator on 10 March 2011. A 26 year-old male subject with no significant medical history was found to have other and unspecified acute pericarditis 12 days after he had received an injection of ACAM2000 (lot number, route and site of administration not reported) on 28 August 2010. Relevant laboratory data included: an abnormal Troponin I with the highest recorded value of 02.05, an abnormal ECG and a normal Echocardiogram. Treatments were not reported. Additional information will be requested from the investigator. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Follow-up information was received on 24 May 2011 via a third party query tool search on the VAERS database, and provided VAERS reference number 418965. Documents held by sender: none.
Age: 26.0
Sex: M
Vaccine: FLU3, FLU3, SMALL, FLUX, SMALL, FLUX, SMALL
Symptoms: Culture negative, Echocardiogram abnormal, Echocardiogram normal, Ejection fraction decreased, Electrocardiogram ST segment elevation
Clinical narrative: This study case was received from the investigator on 10 March 2011. A 26 year-old male subject with no significant medical history was found to have other and unspecified acute pericarditis 12 days after he had received an injection of ACAM2000 (lot number, route and site of administration not reported) on 28 August 2010. Relevant laboratory data included: an abnormal Troponin I with the highest recorded value of 02.05, an abnormal ECG and a normal Echocardiogram. Treatments were not reported. Additional information will be requested from the investigator. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Follow-up information was received on 24 May 2011 via a third party query tool search on the VAERS database, and provided VAERS reference number 418965. Documents held by sender: none.
Age: 26.0
Sex: M
Vaccine: FLU3, FLU3, SMALL, FLUX, SMALL, FLUX, SMALL
Symptoms: Electrocardiogram abnormal, Fatigue, Feeling hot, Fibrin D dimer normal, Full blood count abnormal
Clinical narrative: This study case was received from the investigator on 10 March 2011. A 26 year-old male subject with no significant medical history was found to have other and unspecified acute pericarditis 12 days after he had received an injection of ACAM2000 (lot number, route and site of administration not reported) on 28 August 2010. Relevant laboratory data included: an abnormal Troponin I with the highest recorded value of 02.05, an abnormal ECG and a normal Echocardiogram. Treatments were not reported. Additional information will be requested from the investigator. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Follow-up information was received on 24 May 2011 via a third party query tool search on the VAERS database, and provided VAERS reference number 418965. Documents held by sender: none.
Age: 26.0
Sex: M
Vaccine: FLU3, FLU3, SMALL, FLUX, SMALL, FLUX, SMALL
Symptoms: Gram stain, Gram stain negative, Haematocrit decreased, Headache, Injection site erythema
Clinical narrative: This study case was received from the investigator on 10 March 2011. A 26 year-old male subject with no significant medical history was found to have other and unspecified acute pericarditis 12 days after he had received an injection of ACAM2000 (lot number, route and site of administration not reported) on 28 August 2010. Relevant laboratory data included: an abnormal Troponin I with the highest recorded value of 02.05, an abnormal ECG and a normal Echocardiogram. Treatments were not reported. Additional information will be requested from the investigator. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Follow-up information was received on 24 May 2011 via a third party query tool search on the VAERS database, and provided VAERS reference number 418965. Documents held by sender: none.